Aptagen, LLC
R7-02 ssDNA aptamer scaffold for SARS-CoV-2 RBD (HOLD-selected) (ID# 9703)
DNA
SARS-CoV-2 Spike RBD
Protein
5.702 nM (reported value)
1X PBSMT [consisted of 1× PBS (pH 7.4), 2.5 mM MgCl2 and 0.02% Tween 20]
25°C
heat at 95 °C for 5 minutes, snap-cooled in ice, room temperature for 1 hour
Binds to SARS-CoV-2 Spike RBD (wild type and multiple variants, including Omicron)
3' FAM and 5' Hexynyl modifications on R7-02.
HOLD-selected refers to the selection method used to generate the R7-02 aptamer scaffold–peptide hybrid, and it’s a specialized variant of aptamer selection.
5'-dGpdGpdApdApdGpdApdGpdApdTpdGpdGpdCpdGpdApdCpdApdCpdGpdCpdApdApdTpdCpdGpdTpdGpdGpdGpdTpdTpdGpdGpdGpdGpdApdTpdApdTpdApdApdTpdGpdGpdTpdApdApdGpdCpdTpdGpdApdTpdCpdCpdTpdGpdApdTpdGpdGp-3'
60
18789.2 g/mole
603800 L/(mole·cm)
Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
Lee, M., Kang, B., Lee, J., Lee, J., Jung, S. T., Son, C. Y., & Oh, S. S. (2022). De novo selected hACE2 mimics that integrate hotspot peptides with aptameric scaffolds for binding tolerance of SARS-CoV-2 variants. Science advances, 8(43), eabq6207. https://doi.org/10.1126/sciadv.abq6207
Have your aptamer oligo synthesized ORDER



We are always looking for ways to improve. Please tell us what you think.